Table of Contents Table of Contents
Previous Page  117 / 398 Next Page
Information
Show Menu
Previous Page 117 / 398 Next Page
Page Background

112

Do we tell our patients the truth about numbness after

orthognathic surgery?

L. Rennie

∗

, H. Barry, J. Collyer, K. Sneddon

Queen Victoria Hospital, East Grinstead, United Kingdom

Background:

The incidence of neurosensory deficit or damage to

the inferior dental nerve following mandibular osteotomies varies

widely within the literature. Objective testing figures are often

discussed with patients before surgery, however patient reported

feedback is less frequently discussed.

Objectives:

Determine the incidence of permanent neurosensory

deficit in patients under going bilateral sagittal split osteotomies,

compare the objective findings with patient perceived deficit and

address the effect of deficit on daily living.

Methods:

Patients undergoing bilateral sagittal split osteotomy

procedures were assessed with two-point discrimination preoper-

atively and then again at two-years postsurgery. Those assessed

to have a two-point discrimination score score

≥

3 mm were

regarded as presenting with measurable neurosensory deficit. At

the two-year review patients completed a questionnaire addressing

perceived numbness and its impact on daily living.

Findings and Conclusion:

78 patients were examined and 32%of

patients were found to have objective neurosensory deficit from

the two-point discrimination testing. 71% of patients, however,

reported a perceived numbness. Of these, 70.9% of patients stated

it “did not affect them” at all. Only 7% of patients with perceived

numbness stated it affected their lives “a lot”. Overall 96.2%would

recommend the surgery again.

Patient perception of numbness is perhaps a more important

measure than objective testing especially considering the dispar-

ity between objective and subjective measures. We can however

inform patients that most of those that perceive numbness do not

find it impacts heavily on their lives and almost all would still

recommend surgery.

http://dx.doi.org/10.1016/j.ijom.2017.02.394

Effect of hand gesturing on difficulty with deep intravenous

anaesthesia

E. Roginsky Jr.

Sacred Heart Hospital, Allentown, PA, United States

Background:

During deep intravenous sedation some patients

exhibited hand gesturing; adduction of thumb third and fourth fin-

ger and pointing of the first and second finger, with no tremor

evident. We noted this seemed to accompany anxious or uncoop-

erative anaesthetic cases.

Objectives:

Identify hand gesturing and explore possible connec-

tion with sedation difficulty.

Methods:

Gesturing cases noted and data collected. Precise

description of hand gesturing was used to alert staff to its appear-

ance and enlist their help in recognising it. Photographs were taken

when possible.

Results:

One operator; 680 patients treated; 43 clinical sessions;

12 patients (1.76%) with gesturing. Of these, nine showed anx-

ious, uncooperative or even combative behaviour, while three did

not. Control was 23 patients (3.38%) without gesturing but with

uncooperative behaviour. Patients received varying dosages of

midazolam, fentanyl, ketamine and propofol. One patient with

gesturing received no ketamine.

Findings:

12 patients showed gesturing, nine of them (67%) were

uncooperative during sedation, compared to 23 out of 668 (3.6%)

uncooperative with no gesturing.

Conclusions:

Gesturing may be marker for anxiety during anaes-

thesia. Despite similar appearance to Parkinson resting tremor, I

found no description of static hand gesturing in the literature as it

relates to sedation or anaesthesia. A questionnaire and long-term

follow-up should be used to identify any connection to substance

abuse or neurologic conditions.

http://dx.doi.org/10.1016/j.ijom.2017.02.395

Esmolol in outpatient oral surgery intravenous deep sedation

E. Roginsky Jr.

Sacred Heart Hospital, Allentown, PA, United States

Background:

Use of short acting beta-adrenergic antagonist

esmolol is a useful adjunct in maxillofacial surgery during general

anaesthesia.

Objective:

To demonstrate safety and effectiveness of esmolol in

outpatient intravenous deep sedation.

Methods:

Cases where esmolol was used for treating tachycardia

or hypertension in outpatient oral and maxillofacial surgery office.

Data collected concurrently with treatment.

Results:

One operator; 2950 patients treated; total of 14 months;

37 patients were given esmolol for clinically significant eleva-

tions in systolic blood pressure (SBP), diastolic blood pressure

(DBP) or heart rate (HR). The average ‘peak’ SBP, DBP and HR

when esmolol was given was 174.9 mm Hg, 105.7 mm Hg and

121.1 bpm, respectively (highest SBP, DBP and HR in study was

221 mm Hg, 130 mm Hg and 168 bpm, respectively). Average

baseline SBP, DBP and HR were 135.4 mm Hg, 86.0 mm Hg and

88.6 bpm, respectively. Average post-treatment SBP, DBP and

HR were 156.2 mm Hg, 100.0 mm Hg and 102.3 bpm, respec-

tively. Average esmolol dosage was 15.0 mg; (range, 5–40 mg).

Average medication dosages were: midazolam 3.93 mg, fentanyl

0.048 mg, ketamine 33.45 mg, propofol 44.86 mg and glycopyrro-

late 0.97 mg.

Conclusions:

Esmolol was safe and effective. Benefits include not

needing to cancel cases due to hypertension, uncontrolled rapid

HR (one patient had HR of 168 bpm) or haemorrhage. Treatment

was well-received (two patients were below 14 years old and one

had asthma). This suggests expanded and more routine use of

esmolol not only for haemodynamics but also to reduce nausea

and opioid requirement

. 1

Reference

Harless, M., Depp, C., Collins, S., & Hewer, I. (2015). Role of esmolol in

perioperative analgesia and anesthesia: a literature review.

AANA J

,

83

,

167–177.

http://dx.doi.org/10.1016/j.ijom.2017.02.396